Sino BiopharmaceuticalSBMFF -4.96%62 Dividend Yield % is 2.13% as of Jun. 25, 2026, which is 148% above its 10-year median of 0.86. GuruFocus rates SBMFF with a GF Score™ of 62/100 and a GF Value™ of $0.68 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 151 Biotechnology companies, Sino Biopharmaceutical ranks better than 62.91% on this metric.
As of today (2026-06-25), the Trailing Annual Dividend Yield of Sino Biopharmaceutical is 2.13%.
Good Sign:
Sino Biopharmaceutical Ltd stock Dividend Yield % is close to 1-year high.
The historical rank and industry rank for Sino Biopharmaceutical's Dividend Yield % or its related term are showing as below:
SBMFF'
s Dividend Yield % Range Over the Past 10 Years
Min: 0.37 Med: 0.86 Max: 3.63
Current: 2.13
During the past 13 years, the highest Dividend Yield of Sino Biopharmaceutical was 3.63%. The lowest was 0.37%. And the median was 0.86%.
SBMFF's Dividend Yield % is ranked better than 62.91% of 151
companies
in the Biotechnology industry
Industry Median: 1.5
vs SBMFF: 2.13
During the past 12 months, Sino Biopharmaceutical's average Dividends Per Share Growth Rate was 54.20% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was -2.10% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 10.30% per year.
During the past 10 years, the average Dividends Per Share Growth Rate was 15.80% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Sino Biopharmaceutical was 58.70% per year. The lowest was -20.60% per year. And the median was 12.60% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Sino Biopharmaceutical (OTCPK:SBMFF) Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Sino Biopharmaceutical Dividend Yield % Related Terms
Sino Biopharmaceutical Dividend Yield % Historical Data
* Premium members only.
The historical data trend for Sino Biopharmaceutical's Dividend Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SBMFF vs VRTX, REGN, ALNY: Dividend Yield % Comparison
For the Biotechnology subindustry, Sino Biopharmaceutical's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sino Biopharmaceutical Dividend Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Sino Biopharmaceutical's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Sino Biopharmaceutical's Dividend Yield % falls into.
Sino Biopharmaceutical Dividend Yield % Calculation
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Sino Biopharmaceutical Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
HKD 0.050000
2026-06-24
2026-06-26
2026-07-20
Cash Dividend
semi-annually
HKD:USD 0.127670
HKD 0.050000
2025-08-29
2025-09-02
2025-09-23
Cash Dividend
semi-annually
HKD:USD 0.128294
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sino Biopharmaceutical (SBMFF) has a Dividend Yield % of 2.13% as of Jun. 25, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on Sino Biopharmaceutical and its competitors. This is 148% above median its historical median of 0.86. Over the past decade, Sino Biopharmaceutical's Dividend Yield % has ranged from 0.37 to 3.63. According to the industry distribution chart, Sino Biopharmaceutical ranks #56 out of 151 companies in the Biotechnology industry, placing it in the top 37.1%.
Is Sino Biopharmaceutical's Dividend Yield % too high?
Sino Biopharmaceutical's current Dividend Yield % of 2.13% is 148% above median its 10-year median of 0.86. Over the past 10 years, this metric has ranged from a low of 0.37 to a high of 3.63. The Biotechnology industry median Dividend Yield % is 1.50. Sino Biopharmaceutical's value of 2.13% is 42% above this industry median. Based on the distribution chart, Sino Biopharmaceutical ranks #56 out of 151 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Sino Biopharmaceutical has a GF Score™ of 62/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sino Biopharmaceutical's Dividend Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Sino Biopharmaceutical ranks #56 out of 151 companies for Dividend Yield %. This puts Sino Biopharmaceutical in the upper half of its industry. The industry median Dividend Yield % is 1.50. Sino Biopharmaceutical's value of 2.13% is 42% above this benchmark. Historically, Sino Biopharmaceutical's own Dividend Yield % has ranged from 0.37 to 3.63 over the past decade. While the company's 10-year median is 0.86 vs. the industry median of 1.50, Sino Biopharmaceutical has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Biotechnology company?
The median Dividend Yield % among Biotechnology companies is 1.50, based on 151 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sino Biopharmaceutical's current Dividend Yield % of 2.13% is 42% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on Sino Biopharmaceutical and its competitors. For the Biotechnology industry, the median Dividend Yield % is 1.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sino Biopharmaceutical's current Dividend Yield % is 2.13%, which is 148% above median its own 10-year median of 0.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sino Biopharmaceutical stock overvalued right now?
Based on GuruFocus' analysis, Sino Biopharmaceutical (SBMFF) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.68, compared to a current price of $0.60 — trading 11.5% below its estimated fair value. The current Dividend Yield % is 2.13%, which is 148% above median its 10-year median of 0.86 and 42% above the Biotechnology industry median of 1.50. Sino Biopharmaceutical's overall GF Score™ is 62/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For Sino Biopharmaceutical (SBMFF), the current Dividend Yield % is 2.13% as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sino Biopharmaceutical (SBMFF) Overvalued in 2026?
Based on GuruFocus' analysis, Sino Biopharmaceutical stock appears to be undervalued.
The current stock price of $0.60 is trading 11.5% below its estimated GF Value™ of $0.68.
GuruFocus considers Sino Biopharmaceutical to be Modestly Undervalued.
Key valuation signals for SBMFF:
Dividend Yield %: 2.13% (148% above median its 10-year median of 0.86)
GF Value™: $0.68 vs. price of $0.60 (11.5% below fair value)
Industry Position: 42% above the Biotechnology median (#56 of 151)
No single metric tells the full story. See the SBMFF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sino Biopharmaceutical Ltd is an investment holding company. The company and its subsidiaries are principally engaged in the research and development, production and sale of a series of pharmaceutical products. Its business covering the entire industrial chain of R&D, production and commercialization of drugs, biological products and high-end generic drugs. The company's therapeutic areas include: oncology, liver disease, respiratory, and surgery/pain relief. The company's revenue was generated from the sale of pharmaceutical products in the Chinese mainland.
62GF Score
Get the complete analysis for SBMFF
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SBMFF has been successfully added to your 
